425 results on '"Bioque, Miquel"'
Search Results
2. Differences in total and differential white blood cell counts and in inflammatory parameters between psychiatric inpatients with and without recent consumption of cannabinoids, opioids, or cocaine: A retrospective single-center study
3. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia
4. Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?
5. Elevated Extracellular Free-Water in a Multicentric First-Episode Psychosis Sample, Decrease During the First 2 Years of Illness.
6. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
7. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
8. Deep brain stimulation and digital monitoring for patients with treatment-resistant schizophrenia and bipolar disorder: A case series
9. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
10. The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study
11. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort
12. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
13. Epigenetic clocks in relapse after a first episode of schizophrenia
14. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia
15. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
16. Identifying digital biomarkers of illness activity and treatment response in bipolar disorder with a novel wearable device (TIMEBASE): protocol for a pragmatic observational clinical study.
17. Maintenance Electroconvulsive Therapy in Catatonia: Clinical Profiles From a Case Series.
18. Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder
19. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis
20. Cognitive clusters in first-episode psychosis
21. The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years
22. The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds
23. Targeting the microbiome-gut-brain axis for improving cognition in schizophrenia and major mood disorders: A narrative review
24. Clinical remission in a cohort of first-episode psychosis: Data from the PEPs study
25. Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
26. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis
27. Electroconvulsive therapy protocol adaptation during the COVID-19 pandemic
28. The role of genetics in cognitive remediation in schizophrenia: A systematic review
29. Actitud de los psiquiatras respecto al uso de olanzapina en la práctica clínica: una encuesta nacional
30. Acute effects of a session of electroconvulsive therapy on brain-derived neurotrophic factor plasma levels
31. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)
32. Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment
33. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis.
34. Clinical Experience on the Use of a Single-day, Two-injection Start Initiation Regimen of Aripiprazole Once Monthly in Patients With Schizophrenia in Spain: SaTISfy Study.
35. Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism
36. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis
37. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis
38. THE OTHER VICTIMS OF COVID-19: THE VALUE OF ELECTROCONVULSIVE THERAPY
39. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
40. Gene-environment interaction as a predictor of early adjustment in first episode psychosis
41. Modelling gene-environment interaction in first episodes of psychosis
42. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study
43. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
44. Cannabis use, COMT, BDNF and age at first-episode psychosis
45. Psychiatrists’ attitudes towards the treatment of people with a first episode of psychosis in Catalonia
46. Hard variables for shared decision-making in antipsychotic maintenance treatment
47. Obstetric complications and clinical presentation in first episode of psychosis
48. Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
49. The search for new biomarkers for cognition in schizophrenia
50. Búsqueda De Nuevos Biomarcadores De La Cognición En Esquizofrenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.